Merck Loses Patent For Cancer Diagnostic Tool On Appeal
European appellate officials revoked a Merck patent related to cancer treatment, ruling that its patented claims went beyond what the company originally filed in its application....To view the full article, register now.
Already a subscriber? Click here to view full article